Tech Company Financing Transactions
MIMETAS Funding Round
Bruker participated in a funding round for MIMETAS. The round was announced by the company on 8/10/2026.
Transaction Overview
Company Name
Announced On
8/10/2026
Transaction Type
Venture Equity
Amount
Unknown
Round
Undisclosed
Investors
Proceeds Purpose
The company intends to use the funds to scale its platforms, expand global availability of its human tissue models, and develop integrated product and service workflows that connect its systems with Bruker's technologies.
Company Information
Company Status
Private & Independent
Industry
Life Sciences
Mailing Address
De Limes 7,? Biopartner Building 5?
Oegstgeest?, 2342 DH
The Netherlands
Oegstgeest?, 2342 DH
The Netherlands
Phone
Website
Email Address
Overview
Every year, drugs fail in late-stage trials because traditional models can't accurately predict how they'll function in humans. At MIMETAS, we're changing that. We create the world's most advanced human tissue and disease models using our organ-on-a-chip technology -- enabling faster development of safer and more effective therapies that improve patient lives. Our mission is to develop the world's most advanced in vitro models to support the creation of breakthrough medicines for today's unmet medical needs. We envision a future where every new medicine is developed and tested using advanced 3D human tissue and disease models -- accelerating innovation, lowering costs, and saving lives.
Management Team
Title
Name
Email & Social
Browse more venture capital transactions:
Prev: 8/10/2026: Diald AI venture capital transaction
Next: 8/10/2026: Edgify venture capital transaction
Share this article
About Database of VC Transactions
We do our best to report on funding rounds that are announced publicly. VC investment data records reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs








